5th Circ. Rejects Generic Preemption Argument
A federal appeals court has ruled that the federal regulatory approval process does not protect makers of generic drugs from lawsuits under state failure-to-warn laws, affirming a lower court ruling against...To view the full article, register now.
Already a subscriber? Click here to view full article